knowledge -WSS

knowledge

author：explore 2025-10-01 22:48:28 - browse：16552

Amylyx founders — Justin Klee (left) and Joshua Cohen are the co-founders and co-CEOs of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

Amylyx Pharmaceuticals said Friday that its treatment for ALS, called Relyvrio, failed to provide any benefit for patients in a large clinical trial — a stunning outcome that now has the company considering a voluntary withdrawal of the approved medicine from the market.

“This is really hard for us, and it’s really hard for our team who care so much, but it’s so much harder for people with ALS and their families, and we have to keep that perspective,” said a somber Justin Klee, Amylyx’s co-founder and co-CEO, in an interview with STAT on Thursday evening.

In the Phase 3 study involving 664 people with ALS, Relyvrio failed to outperform a placebo on an ALS functional rating scale that measures the ability to perform daily living tasks, walk, breathe, speak, and swallow. The company did not provide detailed results for the study’s primary goal, but said the calculation for statistical significance was 0.67 — well above the 0.05 threshold for success and an indication that Relyvrio provided no benefit at all.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： 'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

hotspot

WSS

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

2 million sign

Adele warns fans about throwing things at performers onstage

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

focus

knowledge

hotspot

Activists slam private health insurers over coverage restrictions

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Medicare proposal to cover medical devices draws a mixed reaction

AstraZeneca lung cancer study comes in below expectations

Hepatitis C has a cure — but many Americans still lack access to it

Crowdfunding for unproven stem cell procedures spreads misinformation

Continuity nursing helped my family in our darkest PICU moments

Princess Kate attends Wimbledon with Roger Federer: See the photos

Anesthesiologist group: stop taking Ozempic before surgery

Use doctors trained outside the U.S. to ease the physician shortage

hotspot

2 million sign

2 million sign

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

AstraZeneca lung cancer study comes in below expectations

hotspot

hotspot

focus

leisure time